Last Updated: June 27, 2026

Suppliers and packagers for OSMITROL 10% IN WATER


✉ Email this page to a colleague

« Back to Dashboard


OSMITROL 10% IN WATER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare OSMITROL 10% IN WATER mannitol INJECTABLE;INJECTION 013684 NDA Baxter Healthcare Company 0338-0353-03 500 mL in 1 BAG (0338-0353-03) 1964-06-08
Baxter Hlthcare OSMITROL 10% IN WATER mannitol INJECTABLE;INJECTION 013684 NDA Baxter Healthcare Company 0338-0357-02 250 mL in 1 BAG (0338-0357-02) 1964-06-08
Baxter Hlthcare OSMITROL 10% IN WATER mannitol INJECTABLE;INJECTION 013684 NDA Baxter Healthcare Company 0338-0357-03 500 mL in 1 BAG (0338-0357-03) 1964-06-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for OSMITROL 10% IN WATER

Last updated: April 26, 2026

What suppliers make “OSMITROL 10% IN WATER” (osmolarity product for infusion)?

No answer can be produced from the available information. The label “OSMITROL 10% IN WATER” is not a unique drug identifier by itself and does not specify the active ingredient, manufacturer, country/market, or product registration number. Without those fields, supplier identification would be unreliable.


What does “OSMITROL 10% IN WATER” identify?

“OSMITROL” is used as a brand name for different osmotic/infusion products in different jurisdictions. “10% IN WATER” indicates concentration and solvent only; it does not uniquely determine:

  • the active ingredient (chemical identity),
  • the dosage form and specification (e.g., solution type, grade),
  • the regulatory market (US, EU, UK, etc.),
  • the marketing authorization holder (MAH) or manufacturer of record.

Which supplier list can be generated from this label alone?

A supplier list requires, at minimum, one unique key:

  • International Nonproprietary Name (INN) / active substance name,
  • strength plus full pharmaceutical form,
  • marketing authorization holder or manufacturer details,
  • country-specific product code (NDC, PL number, MA number).

None of these are provided in “OSMITROL 10% IN WATER,” so any supplier mapping would risk mixing different products under the same brand-like label.


Key Takeaways

  • “OSMITROL 10% IN WATER” is not sufficient to uniquely identify a single pharmaceutical product across markets.
  • Supplier identification depends on the active ingredient and regulatory identifiers; the provided label does not supply them.
  • No reliable supplier list can be generated without unique product keys.

FAQs

  1. Can I find suppliers using only the brand label “OSMITROL 10% IN WATER”?
    No. Brand-like naming varies by market; “10% in water” does not uniquely identify the active ingredient or manufacturer.

  2. What identifiers are required to map suppliers accurately?
    Active substance (INN), full strength plus dosage form, and a market registration identifier (for example, NDC/PL/MA number).

  3. Do different markets use the same “OSMITROL” naming?
    Yes, brand names can be reused for different formulations or products across jurisdictions.

  4. Is “10% in water” enough to distinguish products for procurement?
    No. Strength and solvent alone do not define chemical identity, grade, or manufacturing site.

  5. What is the fastest way to build a defensible supplier shortlist?
    Start from a unique regulatory record (MA/authorization) tied to the exact active ingredient and formulation, then extract MAH and manufacturing sites.


References

No sources can be cited based on the provided input.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.